Orphan Drug

Drugs that aren't developed by the pharmaceutical business for economic reasons however that answer public health want. Orphan drugs' area unit supposed to treat diseases therefore rare that sponsors area unit reluctant to develop them below regular promoting conditions. the method from the invention of a replacement molecule to its promoting is long, high-priced and really unsure. Developing a drug expecting to treat a rare sickness doesn't permit the recovery of the capital invested with for its analysis.

 

    Related Conference of Orphan Drug

    June 22-23, 2026

    24th European Pathology Congress

    Paris, France
    July 23-24, 2026

    6th World Pathology Conference

    Amsterdam, Netherlands
    March 29-30, 2027

    25th Annual Pathology Congress

    Dubai, UAE

    Orphan Drug Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in